1. Home
  2. MYNZ vs ALBT Comparison

MYNZ vs ALBT Comparison

Compare MYNZ & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • ALBT
  • Stock Information
  • Founded
  • MYNZ 2021
  • ALBT 2014
  • Country
  • MYNZ Germany
  • ALBT United States
  • Employees
  • MYNZ N/A
  • ALBT N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MYNZ Health Care
  • ALBT Health Care
  • Exchange
  • MYNZ Nasdaq
  • ALBT Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • ALBT 9.5M
  • IPO Year
  • MYNZ 2021
  • ALBT N/A
  • Fundamental
  • Price
  • MYNZ $0.35
  • ALBT $0.42
  • Analyst Decision
  • MYNZ Buy
  • ALBT
  • Analyst Count
  • MYNZ 2
  • ALBT 0
  • Target Price
  • MYNZ $3.00
  • ALBT N/A
  • AVG Volume (30 Days)
  • MYNZ 1.4M
  • ALBT 87.9K
  • Earning Date
  • MYNZ 08-13-2024
  • ALBT 08-12-2024
  • Dividend Yield
  • MYNZ N/A
  • ALBT N/A
  • EPS Growth
  • MYNZ N/A
  • ALBT N/A
  • EPS
  • MYNZ N/A
  • ALBT N/A
  • Revenue
  • MYNZ $895,479.00
  • ALBT $959,516.00
  • Revenue This Year
  • MYNZ $67.40
  • ALBT N/A
  • Revenue Next Year
  • MYNZ $191.13
  • ALBT N/A
  • P/E Ratio
  • MYNZ N/A
  • ALBT N/A
  • Revenue Growth
  • MYNZ 69.00
  • ALBT 6.08
  • 52 Week Low
  • MYNZ $0.32
  • ALBT $0.24
  • 52 Week High
  • MYNZ $4.71
  • ALBT $1.70
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 37.39
  • ALBT 44.94
  • Support Level
  • MYNZ $0.39
  • ALBT $0.45
  • Resistance Level
  • MYNZ $0.46
  • ALBT $0.49
  • Average True Range (ATR)
  • MYNZ 0.07
  • ALBT 0.05
  • MACD
  • MYNZ 0.01
  • ALBT -0.01
  • Stochastic Oscillator
  • MYNZ 13.88
  • ALBT 8.04

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: